China Pharma Holdings, Inc. (CPHI)
NYSEAMERICAN: CPHI · Real-Time Price · USD
0.193
-0.008 (-3.75%)
At close: Nov 22, 2024, 4:00 PM
0.192
-0.001 (-0.26%)
After-hours: Nov 22, 2024, 7:53 PM EST

China Pharma Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
445231910
Upgrade
Market Cap Growth
139.68%-19.49%-78.32%17.59%88.26%-8.00%
Upgrade
Enterprise Value
7813302616
Upgrade
Last Close Price
0.190.604.7924.1322.2911.84
Upgrade
PS Ratio
0.470.570.612.371.790.94
Upgrade
PB Ratio
0.530.531.153.802.431.12
Upgrade
P/TBV Ratio
1.870.951.993.892.481.14
Upgrade
P/FCF Ratio
-----21.85
Upgrade
P/OCF Ratio
-----16.96
Upgrade
EV/Sales Ratio
1.261.141.603.102.421.45
Upgrade
EV/EBITDA Ratio
-4370.46-131.65259.95-
Upgrade
EV/FCF Ratio
-----33.46
Upgrade
Debt / Equity Ratio
0.610.622.042.080.930.72
Upgrade
Debt / EBITDA Ratio
-58.59-39.1037.57-
Upgrade
Debt / FCF Ratio
-----14.02
Upgrade
Asset Turnover
0.380.410.400.440.500.32
Upgrade
Inventory Turnover
2.382.052.552.642.442.18
Upgrade
Quick Ratio
0.230.310.190.530.130.17
Upgrade
Current Ratio
0.790.880.470.860.470.56
Upgrade
Return on Equity (ROE)
-75.07%-52.43%-77.08%-48.49%-33.25%-104.99%
Upgrade
Return on Assets (ROA)
-19.85%-10.04%-10.97%-8.17%-7.43%-6.27%
Upgrade
Return on Capital (ROIC)
-25.96%-13.68%-14.06%-10.54%-10.30%-7.68%
Upgrade
Earnings Yield
-128.00%-77.22%-80.22%-14.88%-14.76%-200.61%
Upgrade
FCF Yield
-20.25%-17.84%-16.39%-3.01%-4.68%4.58%
Upgrade
Buyback Yield / Dilution
-616.92%-221.82%-13.96%-5.74%-0.10%-
Upgrade
Total Shareholder Return
-616.92%-221.82%-13.96%-5.74%-0.10%-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.